B Tom, P De Vries, J P C Heiligers, E W Willems, K Kapoor, G W John, P R Saxena
Index: Cephalalgia 22(1) , 37-47, (2002)
Full Text: HTML
We investigated the effects of donitriptan, which possesses a uniquely high affinity and efficacy at 5-HT1B/1D receptors, on carotid and systemic haemodynamics in anaes thetized pigs. Donitriptan (0.16-100 microg kg(-1), i.v.) dose-dependently decreased total carotid blood flow and vascular conductance (maximum response: -25 +/- 3%). This effect was entirely due to a selective reduction in the cephalic arteriovenous anastomotic fraction (maximum response: - 63 +/- 3%; ED50%: 92 +/- 31 nmol/kg); the nutrient vascular conductance increased. Donitriptan did not decrease vascular conductances in or blood flow to a number of organs, including the heart and kidneys; in fact, vascular conductances in the skin, brain and skeletal muscles increased. Cardiac output was slightly decreased by donitriptan, but this effect was confined to peripheral arteriovenous anastomoses. The haemodynamic effects of donitriptan were substantially reduced by the 5-HT1B/1D receptor antagonist GR127935. These results show that donitriptan selectively constricts arteriovenous anastomoses via 5-HT1B receptor activation. The drug should be able to abort migraine headaches and it is unlikely to compromize blood flow to vital organs.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Donitriptan monohydrochloride
CAS:170911-68-9 |
C23H26ClN5O2 |
Donitriptan, but not sumatriptan, inhibits capsaicin-induced...
2006-09-01 [Br. J. Pharmacol. 149(1) , 82-91, (2006)] |
Donitriptan (Pierre Fabre).
2001-03-01 [Curr. Opin. Investig. Drugs 2(3) , 415-8, (2001)] |
Comparison of contractile responses to donitriptan and sumat...
2002-05-17 [Eur. J. Pharmacol. 443(1-3) , 125-32, (2002)] |
An in vivo rat model to study calcitonin gene related peptid...
2001-05-01 [Pain 92(1-2) , 101-6, (2001)] |
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with ...
1999-07-01 [J. Pharmacol. Exp. Ther. 290(1) , 83-95, (1999)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved